clinical_evidence_category_top_pc_2486x640.png
clinical_evidence_category_top_sp_750x600.png

Clinical Evidence

Learn more about the clinical evidence behind our products and intervention techniques
Interventional Cardiology
Comparable clinical outcomes of Ultimaster™ stent with bioresorable polymer coating versus Xience stent with durable polymer coating are maintained up to five years. Particularly remarkable was the low rate of…
Interventional Cardiology
5-year clinical outcomes of PCI-treated bifurcation lesions whereby a single stent approach was utilized in 93% of the cases showed similar good safety and efficacy for both Ulimaster™ and Xience stents.…
Interventional Cardiology
This study reveals, that throughout the 5-year follow-up period, sirolimus-eluting bioresorbable polymer Ultimaster™ stent (BP-SES), displays similarly good long-term safety and efficacy profile as the…
Interventional Cardiology
The trial compares the novel distal radial access with conventional radial access approach, in terms of radial occlusion rates (RAO) at discharge. DISCO RADIAL is the first large international randomized study…
Interventional Cardiology
DISCOVERY 1TO3 demonstrated rapid strut coverage of UltimasterTM DES, with the majority of strut coverage process taking place within the first month after stent implantation. The unique sequential OFDI…
Interventional Cardiology
37,198 patients enrolled: The biggest real world BP-DES registry in the world. Excellent performance with a TLF rate < 5% in all continents and stent thrombosis rate < 1%.
Interventional Cardiology
4,395 patients with Bifurcation lesions treated with Ultimaster™ DES showed acceptable clinical outcomes with TLF 5.1%. Ultimaster™ with POT technique improve clinical outcomes.
Interventional Cardiology
1,099 patients with Left main lesions treated with Ultimaster™ DES showed acceptable clinical outcomes.
Interventional Cardiology
MASTER DAPT compares abbreviated vs. prolonged DAPT, following implantation with Ultimaster™ or Ultimaster™ Tansei™, in approx. 4,500 "all-comer" patients.
Interventional Cardiology
Interventional Oncology
To compare angiographic and pathologic effects (ie, occlusion, recanalization) after embolization with Hydrogel-coated coils and fibered coils in the renal and internal iliac arteries after 7 days and 1 and 4…
Interventional Cardiology
MODEL U-SES trial demonstrated that 3-month DAPT was non-inferiority to adjusted cohort of longer DAPT after BP-SES implantation in net adverse clinical events. P2Y12 inhibitor monotherapy was almost…
Interventional Cardiology
The objectives of this study is to confirm reduction of door-to-balloon (D2B) time with single-catheter percutaneous coronary intervention (SC-PCI) method. Ikari left curve was reported as a universal guiding…
Interventional Cardiology
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention (Complex Large Bore Radial PCI) The COLOR trial is - A multicenter prospective randomized…
Interventional Oncology
To evaluate the usefulness of hydrogel-coated coils for preventing recanalization after coil embolization of pulmonary arteriovenous malformations (PAVMs).
Interventional Oncology
To evaluate the safety and effectiveness of hydrogel-coated coils for vessel occlusion in the body trunk.